Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Marsh

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
BMC Medical Genetics|May 11, 2005
CYP3A4 and CYP3A5 genotyping by PyrosequencingAdam A Garsa, Howard L McLeod, Sharon Marsh
Cancer Research|October 16, 2003
Ferredoxin reductase: pharmacogenomic assessment in colorectal cancerJinsheng Yu, Sharon Marsh, Ranjeet Ahluwalia, et al.
Pharmacogenomics|June 7, 2006
Global pharmacogenetics: giving the genome to the massesSharon Marsh, Derek J Van Booven, Howard L McLeod
Clinical Chemistry|September 23, 2003
Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenaseRanjeet Ahluwalia, Robert Freimuth, Howard L McLeod, et al.
Future Science OA|December 30, 2016
A Bridging Opportunities Work-frame to develop mobile applications for clinical decision makingTibor van Rooij, Serena Rix, James B Moore, et al.
Gastroenterology Research and Practice|June 2, 2016
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundJinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Pharmacogenomics|November 22, 2005
Concordance of pharmacogenetic markers in germline and colorectal tumor DNASharon Marsh, Mary Ann Mallon, Paul Goodfellow, et al.
Gastroenterology Research and Practice|June 2, 2016
Gut Microbiota and Metagenomic Advancement in Digestive DiseaseJinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Therapeutic Drug Monitoring|September 24, 2004
CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjectsDavid I Min, Vicki L Ellingrod, Sharon Marsh, et al.
Journal of Human Genetics|August 24, 2004
Distribution of ITPA P32T alleles in multiple world populationsSharon Marsh, Cristi R King, Ranjeet Ahluwalia, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
BMC Medical Genetics|May 11, 2005
CYP3A4 and CYP3A5 genotyping by PyrosequencingAdam A Garsa, Howard L McLeod, Sharon Marsh
Cancer Research|October 16, 2003
Ferredoxin reductase: pharmacogenomic assessment in colorectal cancerJinsheng Yu, Sharon Marsh, Ranjeet Ahluwalia, et al.
Pharmacogenomics|June 7, 2006
Global pharmacogenetics: giving the genome to the massesSharon Marsh, Derek J Van Booven, Howard L McLeod
Clinical Chemistry|September 23, 2003
Use of pyrosequencing to detect clinically relevant polymorphisms in dihydropyrimidine dehydrogenaseRanjeet Ahluwalia, Robert Freimuth, Howard L McLeod, et al.
Future Science OA|December 30, 2016
A Bridging Opportunities Work-frame to develop mobile applications for clinical decision makingTibor van Rooij, Serena Rix, James B Moore, et al.
Gastroenterology Research and Practice|June 2, 2016
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundJinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Pharmacogenomics|November 22, 2005
Concordance of pharmacogenetic markers in germline and colorectal tumor DNASharon Marsh, Mary Ann Mallon, Paul Goodfellow, et al.
Gastroenterology Research and Practice|June 2, 2016
Gut Microbiota and Metagenomic Advancement in Digestive DiseaseJinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Therapeutic Drug Monitoring|September 24, 2004
CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjectsDavid I Min, Vicki L Ellingrod, Sharon Marsh, et al.
Journal of Human Genetics|August 24, 2004
Distribution of ITPA P32T alleles in multiple world populationsSharon Marsh, Cristi R King, Ranjeet Ahluwalia, et al.
Pageof 9